Contents

CNS & Neurological Disorders - Drug Targets , Volume 6 - Number 2

Editorial [Hot Topic:Depression (Part 1) (Guest Editors: John H. Kehne and Ronald S. Duman)]

, 6(2): 85 - 86

Ronald S. Duman and John H. Kehne


DOI: 10.2174/187152707780363249




Metabotropic Glutamate Receptors in the Control of Mood Disorders

, 6(2): 87 - 100

Jeffrey M. Witkin, Gerard J. Marek, Bryan G. Johnson and Darryle D. Schoepp


DOI: 10.2174/187152707780363302




The NMDA Receptor as a Therapeutic Target in Major Depressive Disorder

, 6(2): 101 - 115

Christopher Pittenger, Gerard Sanacora and John H. Krystal


DOI: 10.2174/187152707780363267




AMPA Receptors in the Therapeutic Management of Depression

, 6(2): 117 - 126

D. Bleakman, A. Alt and J. M. Witkin


DOI: 10.2174/187152707780363258




GABAergic Contributions to the Pathophysiology of Depression and the Mechanism of Antidepressant Action

, 6(2): 127 - 140

Gerard Sanacora and Aybala Saricicek


DOI: 10.2174/187152707780363294




Triple Reuptake Inhibitors (“Broad Spectrum” Antidepressants)

, 6(2): 141 - 149

Phil Skolnick and Anthony S. Basile


DOI: 10.2174/187152707780363285




Targeting Neurotrophic/Growth Factor Expression and Signaling for Antidepressant Drug Development

, 6(2): 151 - 160

Keith Q. Tanis, Samuel S. Newton and Ronald S. Duman


DOI: 10.2174/187152707780363276




Webmaster Contact: info@benthamscience.org
Copyright © 2018 Bentham Science